Latest Publications
Insulin and GLP-1 Peptides: What Crystallization Can Teach Us
Part 2 of 3 | Improved Pharma peptide crystallization series by Stephen R. Byrn. Ph.D. Insulin and GLP-1 receptor agonists belong in the same conversation about peptide medicines, but their crystallization histories are veryRead more
Why Crystallize Therapeutic Peptides
Part 1 of 3 | Improved Pharma peptide crystallization series by Stephen R. Byrn Peptide medicines have moved far beyond insulin. They now include treatments for metabolic, endocrine, gastrointestinal, and other diseases. Yet forRead more
Improved Pharma exhibiting and presenting at AAPS 2026 PHARMSCI 360
Meet us at Booth #1518 and posters W1030-04-20 and W1130-09-52. WEST LAFAYETTE, Ind., Oct. 14, 2026 /PRNewswire/ -- This year, Improved Pharma occupies a larger corner booth (#1518) shared with Varda Space Industries (#1520). We areRead more
ESTABLISHING SAMENESS OF AMORPHOUS MATERIALS
Stephen Byrn, Pamela Smith, David Engers Comparability intended to describe the sameness of amorphous materials can be assessed in a scientifically and pharmaceutically meaningful way. More specifically, it addresses how amorphous drug substances orRead more
Establishing Polymorph Structure in Early Pharmaceutical Development
Stephen Byrn, David Engers, Pamela Smith In the modern landscape of pharmaceutical development, it is increasingly understood that a medicine is more than just a molecule because the solid form of an active pharmaceuticalRead more
Hot off the Press: Recent Publications from Improved Pharma and Varda Space Industries Collaboration
Improved Pharma contributes to dual publications detailing the successful recovery and analysis of a metastable form of Ritonavir space-generated, and the single crystal growth and structure solution of Nirmatrelvir Form 2. WEST LAFAYETTE, Ind.,Read more
Solving Pharmaceutical Problems
We are a research and information company dedicated to improving pharmaceutical methods, formulations, and processes.